increased use of spironolactone for heart failure is causing more hospitalizations and deaths

The increased use of spironolactone for heart failure is causing more hospitalizations and deaths.

The problem started a few years ago when the "Randomized Aldactone Evaluation Study" (RALES) showed improved outcomes in patients with severe heart failure.

Since that study was published, lots of heart failure patients were put on spironolactone.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: MD includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote